Financial results - NEFES CHAYARO PHARM SRL

Financial Summary - Nefes Chayaro Pharm Srl
Unique identification code: 37492026
Registration number: J05/1028/2017
Nace: 7500
Sales - Ron
282.216
Net Profit - Ron
10.607
Employee
2
The most important financial indicators for the company Nefes Chayaro Pharm Srl - Unique Identification Number 37492026: sales in 2023 was 282.216 euro, registering a net profit of 10.607 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nefes Chayaro Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 18.273 75.506 110.925 177.742 195.378 274.056 282.216
Total Income - EUR - - - 18.440 76.237 112.794 183.268 197.914 283.475 286.310
Total Expenses - EUR - - - 17.038 63.919 97.476 160.362 175.648 255.141 272.880
Gross Profit/Loss - EUR - - - 1.402 12.318 15.319 22.907 22.266 28.334 13.429
Net Profit/Loss - EUR - - - 1.218 11.131 14.201 21.195 20.335 25.969 10.607
Employees - - - 1 1 1 1 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 3.3%, from 274.056 euro in the year 2022, to 282.216 euro in 2023. The Net Profit decreased by -15.283 euro, from 25.969 euro in 2022, to 10.607 in the last year.

Check the financial reports for the company - Nefes Chayaro Pharm Srl

Rating financiar

Financial Rating -
Nefes Chayaro Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nefes Chayaro Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nefes Chayaro Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nefes Chayaro Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nefes Chayaro Pharm Srl - CUI 37492026

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 119 70 23 0 0 0 0
Current Assets - - - 5.583 19.741 35.299 57.895 78.876 105.683 54.046
Inventories - - - 5.091 17.892 31.461 52.422 67.883 60.330 45.792
Receivables - - - 0 1.220 2.953 3.852 4.063 4.156 5.359
Cash - - - 492 629 886 1.621 6.930 41.198 2.896
Shareholders Funds - - - 1.261 12.369 26.330 47.026 66.318 92.493 25.998
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 4.440 7.441 8.992 10.869 12.558 13.190 28.049
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 54.046 euro in 2023 which includes Inventories of 45.792 euro, Receivables of 5.359 euro and cash availability of 2.896 euro.
The company's Equity was valued at 25.998 euro, while total Liabilities amounted to 28.049 euro. Equity decreased by -66.215 euro, from 92.493 euro in 2022, to 25.998 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nefes Chayaro Pharm Srl

Comments - Nefes Chayaro Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.